The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Young-onset colorectal cancer (YOCRC) in the nationwide precision oncology trial IMPRESS-Norway.
 
Sebastian Meltzer
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BMS Norway (Inst); Illumina (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
 
Hege Elvebakken
No Relationships to Disclose
 
Eli Steinskog
No Relationships to Disclose
 
Irja Oppdal
No Relationships to Disclose
 
Kjersti Hestetun
No Relationships to Disclose
 
Åsmund Flobak
No Relationships to Disclose
 
Sigmund Brabrand
No Relationships to Disclose
 
Ase Haug
No Relationships to Disclose
 
Pitt Niehusmann
No Relationships to Disclose
 
Cecilie Torkildsen
No Relationships to Disclose
 
Egil Blix
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche
 
Kathinka Slørdahl
No Relationships to Disclose
 
Katarina Puco
Consulting or Advisory Role - Astellas Pharma; Bayer Norway; Bristol-Myers Squibb; Ipsen; MSD; Pfizer
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Incyte (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
 
Kristine Aasebø
No Relationships to Disclose
 
Anne Ree
No Relationships to Disclose
 
Hanne Hamre
No Relationships to Disclose
 
Sigbjørn Smeland
No Relationships to Disclose
 
Kjetil Tasken
Stock and Other Ownership Interests - Ledidi; Serca Pharmaceuticals
Consulting or Advisory Role - Serca Pharmaceuticals
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Incyte (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Stock and Stock options, and royalty agreement through Oslo University Hospital / University of Oslo Tech Transfer Office Inven2 AS.
Travel, Accommodations, Expenses - Roche
 
Hege Russnes
No Relationships to Disclose
 
Åslaug Helland
No Relationships to Disclose